Episode
Episode 52. Management of Hodgkin Lymphoma in Older Adults with Dr. Andrew Evens
- Podcast
- Blood Cancer Talks
- Published
- Oct 26, 2024
- Duration seconds
- 2548
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/559c7ab0
Actions
POST https://stenobird.com/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-52-management-of-hodgkin-lymphoma-in-older-adults-with-dr-andrew-evens/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/blood-cancer-talks-5570002/episode-52-management-of-hodgkin-lymphoma-in-older-adults-with-dr-andrew-evens.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, we dive into the management of older adults with Hodgkin Lymphoma with Dr. Andrew Evens. Here are the key articles we discussed: 1. Comparison of ABVD versus Stanford V in older Hodgkin Lymphoma patients: https://pmc.ncbi.nlm.nih.gov/articles/PMC3906856/ 2. Outcome of older adults ECHELON-1: https://pubmed.ncbi.nlm.nih.gov/34162178/ 3. Sequential BV-AVD in older adults with Hodgkin Lymphoma: https://pubmed.ncbi.nlm.nih.gov/30179569/ 4. SWOG S1826 trial (Nivo-AVD vs AAVD in advanced stage classical HL): https://pubmed.ncbi.nlm.nih.gov/39413375/ 5. S1826 outcomes in older adults: https://ash.confex.com/ash/2023/webprogram/Paper180114.html 6. Single-agent BV for older adults with Hodgkin: https://ashpublications.org/blood/article/142/Supplement%201/4435/503453